SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles planned stock and bond offerings to finance AI and data-center expansion are driving attention, with traders weighing dilution and debt concerns against managements view that the funding is part of a previously outlined investment plan. Bears criticize the timing and financial risk, while bulls see the capital raise as necessary to support growth.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Marvells agreed all-stock acquisition of Lumentum is driving attention, with traders focused on the fixed share-exchange ratio and the long wait for the deal to close. Many LITE holders object to the terms and worry its value will track Marvells share price, helping explain the selloff despite the announced premium; others see strategic value in combining optics and AI-data-center connectivity businesses.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvells announced all-stock acquisition of Lumentum is driving discussion, as the deal aims to combine Marvells connectivity chips with Lumentums optical technology for AI data centers. Traders are divided: some see strategic value in expanding Marvells optics business, while others worry about shareholder dilution, the deals cost and long path to completion, contributing to selling pressure.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluences CEO, CFO and chief customer success officer are leaving, with interim leaders appointed and permanent searches underway. Traders are split between viewing the shake-up as a chance to reset management and doubting it will fix the companys manufacturing and execution problems; some also speculate about short-squeeze potential.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

Discussion centers on POETs photonics positioning amid Foxconn Tech Day visibility and Marvells Lumentum deal, with traders debating whether industry consolidation validates demand and creates opportunities for POET or intensifies competition. The optimism is tempered by concerns that the Foxconn display is not proof of production orders, with many awaiting shipment and revenue updates at the upcoming earnings report.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

FDA accelerated approval of Inovios competing RRP treatment has raised concerns about pressure on Precigens PAPZIMEOS and prompted a sharp selloff. Traders are divided over the rivals potential treatment advantages versus PAPZIMEOSs commercial head start and established payer access, with upcoming earnings seen as a key test of launch momentum.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsomes Q3 results beat expectations, with strong growth in its commercial portfolio, particularly Auvelity, prompting bullish reactions about the companys path toward cash-flow positivity. The shares decline despite the report has frustrated investors, while others point to rising expenses and the lack of quantified guidance on profitability as reasons for caution.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to fresh 52-week highs ahead of Q3 results has traders focused on BRIUMVIs sales momentum, bullish options activity and the possibility of a short squeeze. Buyout speculation is also prominent, but remains unconfirmed.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus drew attention after reporting quarterly results above expectations and raising its full-year revenue outlook, with growth in oncology testing and Data & Applications supporting the business story. Traders were broadly upbeat about the beat and higher guidance, but some questioned how much the narrower loss reflected underlying improvement, while the shares decline prompted sell the news and volatility concerns.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas preliminary warning that DefenCath reimbursement could decline through 2027 has driven sharp selling, raising concerns about CorMedixs pricing, revenue and customer uptake. Traders disagree on the implications: some view DaVitas estimates as uncertain and point to continued adoption and CMS reimbursement, while others worry about lower economics and competition from ClearGuard.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Michael Burry’s Fiserv Buyout Math Hits $120 — Reaffirms PayPal As A ‘Fat Pitch’ Amid Global Payments Deal Buzz 

Equity

Burry maintained a full Fiserv position, citing stronger profitability and better assets than Global Payments.

FIS Announces Quarterly Dividend

FIS (NYSE: FIS), a global leader in financial services technology, announced a quarterly dividend of $0.44 per common share. The dividend is payable December 28, 2026, to FIS shareholders of record as of close of business on December 14, 2026. About FIS FIS is a financial technology company...

FIS Q3 Earnings: Can Banking Solutions Growth Offset Rising Costs?

Fidelity National nears Q3 earnings with Banking Solutions growth, driven by an acquisition, but rising costs may squeeze profitability. Can revenue gains offset the pressure?

Fidelity National Information Services (FIS) Earnings Expected to Grow: Should You Buy?

Fidelity National (FIS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FIS Research: UK Finance Leaders Back AI in Cash Management, Yet Almost a Third Cannot Measure What It Is Delivering

Nine in 10 (90%) of UK finance leaders have a clear business case for using AI in cash and liquidity management, but only seven in 10 (71%) can clearly measure the business value their AI initiatives deliver, according to new research from FIS (NYSE: FIS), a global leader in financial technology...

FIS Announced New Date for Third Quarter Earnings of November 4, 2026

FIS (NYSE: FIS), a global leader in financial services technology, today announced that its third quarter 2026 financial results conference call has been rescheduled from Tuesday, November 3rd to Wednesday, November 4th, prior to market open. The new date is intended to better accommodate the...

FIS Stock Down Nearly 48% From 52-Week High: Is a Rebound Ahead?

FIS stock has plunged nearly 48% from its 52-week high, but rising free cash flow, expanding margins and acquisition synergies could fuel a potential rebound.

FIS AML Investigations Agent Now Commercially Available to Help Banks Tackle the Scale and Cost of Financial Crime Compliance

FIS (NYSE: FIS) today announced that the FIS AML Investigations Agent that was jointly announced in May 2026 with Anthropic, is now commercially available to any U.S.-based bank, including those that are not FIS clients today. This is the first solution of its kind from a provider that already...

FIS to Report Third Quarter Earnings on November 3, 2026

FIS (NYSE: FIS), a global leader in financial services technology, will announce third quarter 2026 financial results on Tuesday, November 3rd, prior to market open.The company will sponsor a live webcast of its earnings conference call with the investment community beginning at 8:30 a.m. (EST) the...

FIS Stock Trades at a Discount: Should Investors Hold or Buy?

Fidelity National offers a discounted valuation, rising free cash flow and AI-driven growth opportunities, but slower revenue growth and acquisition debt remain key concerns.

Fidelity National Information Services, Inc. engages in the provision of technology solutions for financial institutions and businesses. It operates through the following segments: Banking Solutions, Capital Markets Solutions, and Corporate and Other. The Banking Solutions segment focuses on serving financial institutions with core processing software, transaction processing software, and complementary applications and services. The Capital Markets Solutions segment provides global financial services with buy- and sell-side solutions. The Corporate and Other segment includes corporate overhead expense, leveraged functions, and miscellaneous expenses. The company was founded in 1968 and is headquartered in Jacksonville, FL.

Fidelity National Information Services, Inc.

Bullish Sentiment

<ul class="summary-bullets"><li>Burry’s hypothetical <a class="mention" data-mention="$FISV" data-symbol-id="FISV" href="https://stocktwits.com/symbol/FISV" target="_blank">Fiserv</a> buyout valuation of $100 to $120 implies 100%-140% upside from current levels.</li><li>Burry said deal activity could accelerate Fiserv’s investment case ahead of Tuesday’s earnings.</li><li>He remained cautious on Global Payments and FIS, with his valuation ranges below their share prices.</li></ul>Michael Burry sees a potential takeout value of $100 to $120 per share for payments processor Fiserv (FISV). He also reaffirmed PayPal (PYPL) as a “Fat Pitch” as reported private-equity interest in rival Global Payments (GPN) puts sector valuations in focus.<h2 class="st-heading-2">Burry Sees Opportunity In Fiserv’s ‘Penalty Box’</h2>Burry’s $100-$120 buyout scenario implies upside in the range of 100%-140% from Fiserv’s current market price. He estimated the range by applying valuation assumptions from a potential Global Payments takeover. “Fiserv is far more profitable, only slightly more costly as an acquisition target, and has better assets, relative to Global Payments,” he said in his latest&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://michaeljburry.substack.com/p/trading-post-global-payments-buyout?utm_source=share&amp;utm_medium=android&amp;r=3a7nc">Substack post</a>.He argued that the stock’s struggles partly reflect a loss of investor trust. “Fiserv has been in the penalty box due to a prior management’s overly enthusiastic growth targets and poorly disclosed benefits from Argentine hyperinflation. This credibility gap is not easily restored on Wall Street, even with new management,” he said.Burry maintained a full position and said fresh deal activity could bring forward the potential payoff. “Altogether, I find this circumstance an opportunity,” he said. “Remember, insiders have been significant buyers at these low prices.”The buyout comparison assumes a new owner can change strategy, cut costs, and redirect cash flows. For ordinary shareholders, Burry said Fiserv still traded at about 1.6 times his IV15 benchmark, which is the price at which he expects 15% annualized returns over 15 years.Fiserv reports third-quarter results on Tuesday.<h2 class="st-heading-2">Burry Questions Value Behind Global Payments’ Buyout Rally</h2>Global Payments shares jumped as much as 18% Friday after&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.ft.com/content/da16af06-4431-4ced-9c3e-a0753d8c45c9?syn-25a6b1a6=1">reports</a> that Clayton Dubilier &amp; Rice was pursuing a buyout alongside GTCR, its largest shareholder.&nbsp; GTCR gained 15% of Global Payments through its Worldpay acquisition, completed in January at a $24.25 billion enterprise valuation. Global Payments also sold its Issuer Solutions business to Fidelity National Information Services (FIS).Burry, however, is skeptical of Global Payments’ acquisition strategy and heavily adjusted earnings. “My view, from the point of view of a minority shareholder, has been that Global Payments had little value as a serial acquirer doomed to continue buying companies at a poor rate of return,” he said.Even assuming better capital allocation, his entry-price range for a control buyer seeking 15% annualized returns was $45 to $60, which is about 38%-54% below current levels. At that market price, he estimated a control buyer could earn 10%. His $18-$26 comparison for FIS was about 33%-53% below last closing price.&nbsp;Still, he saw a potential catalyst for rivals. “Nevertheless, a buyout of Global Payments should validate the value of the other legacy payment networks. Perhaps even put them in play,” he said.<h2 class="st-heading-2">Burry Stands By His PayPal ‘Fat Pitch’</h2>Burry remains bullish on PayPal, though he said its business isn't an easy comparison to Global Payments.“I have it today trading at about 0.80x IV15, and it is a Fat Pitch here in the $50s,” he said. He called his position small to normal in size. His bullish stance predates the latest deal speculation. In July, he challenged Stripe and Advent’s $60.50-per-share offer, arguing that a buyer taking control of PayPal should pay more.“$60.50 is just too low. I am not selling, and I believe it is only an opening bid,” he said at the time. Stripe and Advent&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2026-08-28/advent-stripe-consortium-is-said-to-drop-pursuit-of-paypal">reportedly</a> abandoned their pursuit in August.Outside payments, Burry added to Sprouts Farmers Market (SFM) call options expiring in 2028 and JD.com (JD) calls expiring in 2029. He also bought more BYD (BYDFF), calling the automaker a mid-sized position and JD as a large holding.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/pgen-stock-retail-buyout--inovio-rival-crashes-party-before-earnings/cNG9qNsR92t">Precigen Bears Take Over Premarket – But Retail Bulls Still See A Buyout Coming&nbsp;</a>

Michael Burry attends "The Big Short" New York Premiere at Ziegfeld Theater on November 23, 2015 in New York City. (Photo by James Devaney/WireImage)

Michael Burry’s Fiserv Buyout Math Hits $120 — Reaffirms PayPal As A ‘Fat Pitch’ Amid Global Payments Deal Buzz

BYD Co

BYD Co Ltd/ADR

Fiserv, Inc.

Global Payments, Inc.

JD.com Inc - ADR

PayPal Holdings Inc

Sprouts Farmers Market Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

$FIS  at the bottom of stock performance vs its peers, but at the top of CEO compensation

Merlinda

$FIS Future Forward was supposed to put this company back on its feet. Launched in late 2022 with target ending date of end of 2024, they extended in 2025, and then again into 2026. This company is in pepertual reboot mode. We'll see this week if they are reporting more "one time" restructuring charges

Robert

$FIS super bullish, that means they can fire 90% of their staff and have the same product!

Legitimate

$FIS People that were waiting for $30, missed the boat. This bounced off support like a trampoline.

Edward Dean

$FIS so, FIS has been hot particular hard due to the rise of AI. Now that there are doubts with AI, will we begin to else a reversal?

GATA2016

$FIS this company has been selling its people to cognizant, they want to bring up the stock price.

Feed

News

Sentiment

Earnings

Fundamentals

Info

FIS Fidelity National Information Services, Inc.

Fundamentals

Latest FIS News